188
Views
13
CrossRef citations to date
0
Altmetric
Original Research

RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy

, , &
Pages 5747-5756 | Published online: 30 Dec 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yue Zhang, Faliang Ren, Bing Ni, Tao Jing & Jun Tang. (2021) Tumor targeting nanoparticle E749-57-HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model. Human Vaccines & Immunotherapeutics 17:10, pages 3529-3538.
Read now

Articles from other publishers (12)

Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, Giuseppe Salvaggio, Antonino Tuttolomondo & Albert Comelli. (2024) Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. Pharmaceuticals 17:1, pages 126.
Crossref
Yu Hu, Jizheng Song, Anjie Feng, Jieyu Li, Mengqi Li, Yu Shi, Wenxiu Sun & Lingjun Li. (2023) Recent Advances in Nanotechnology-Based Targeted Delivery Systems of Active Constituents in Natural Medicines for Cancer Treatment. Molecules 28:23, pages 7767.
Crossref
Qiran Chen, Long Yuan, Wei-Chun Chou, Yi-Hsien Cheng, Chunla He, Nancy A. Monteiro-Riviere, Jim E. Riviere & Zhoumeng Lin. (2023) Meta-Analysis of Nanoparticle Distribution in Tumors and Major Organs in Tumor-Bearing Mice. ACS Nano 17:20, pages 19810-19831.
Crossref
Weiqiang Han, Fengyu Liu, Yuyao Li, Guoxin Liu, Hongjuan Li, Yongqian Xu & Shiguo Sun. (2023) Advances in Natural Polymer‐Based Transdermal Drug Delivery Systems for Tumor Therapy. Small 19:35.
Crossref
Mehdi Sanati, Amir R. Afshari, Samaneh Aminyavari, Prashant Kesharwani, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2023) RGD-engineered nanoparticles as an innovative drug delivery system in cancer therapy. Journal of Drug Delivery Science and Technology 84, pages 104562.
Crossref
Liyan Yin, Xingchen Li, Rongrong Wang, Yiying Zeng, Zhaowu Zeng & Tian Xie. (2023) Recent Research Progress of RGD Peptide–Modified Nanodrug Delivery Systems in Tumor Therapy. International Journal of Peptide Research and Therapeutics 29:4.
Crossref
Ankita Das, Siuli Shaw, Manaswi Gupta & Sudeep Bose. 2023. Phospholipases in Physiology and Pathology. Phospholipases in Physiology and Pathology 179 196 .
Run Meng, Huimin Zhu, Ziwei Wang, Shilei Hao & Bochu Wang. (2022) Preparation of Drug-Loaded Albumin Nanoparticles and Its Application in Cancer Therapy. Journal of Nanomaterials 2022, pages 1-12.
Crossref
Hailong Tian, Tingting Zhang, Siyuan Qin, Zhao Huang, Li Zhou, Jiayan Shi, Edouard C. Nice, Na Xie, Canhua Huang & Zhisen Shen. (2022) Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies. Journal of Hematology & Oncology 15:1.
Crossref
Yan Jing Yee, Heather A.E. Benson, Crispin R. Dass & Yan Chen. (2022) Evaluation of novel conjugated resveratrol polymeric nanoparticles in reduction of plasma degradation, hepatic metabolism and its augmentation of anticancer activity in vitro and in vivo. International Journal of Pharmaceutics 615, pages 121499.
Crossref
Fatemeh Rezaei-Tazangi, Hossein Roghani-Shahraki, Mahdi Khorsand Ghaffari, Firoozeh Abolhasani Zadeh, Aynaz Boostan, Reza ArefNezhad & Hossein Motedayyen. (2021) The Therapeutic Potential of Common Herbal and Nano-Based Herbal Formulations against Ovarian Cancer: New Insight into the Current Evidence. Pharmaceuticals 14:12, pages 1315.
Crossref
Bijaideep Dutta, K.C. Barick & P.A. Hassan. (2021) Recent advances in active targeting of nanomaterials for anticancer drug delivery. Advances in Colloid and Interface Science 296, pages 102509.
Crossref